QTI · Qt Imaging Holdings, Inc.
$2.67
+0.14 (+5.53%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 12, 2026
The latest filing no longer states the doubt (first flagged May 13, 2026).
View the 10-Q filed Aug 12, 2026Market Cap
$35.86M
Shares
14.64M
Volume · Oct 2
17.48K
Avg daily vol (3M)
33.46K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.67
Open$2.49
Day$2.49–2.67
52W close$2.45–35.85
Avg vol 30d30K
Short int234K · 1.6% float · 7.8d
Short vol26%
Last earningsAug 12, 2026
DataNov 2021–Oct 2026
Filing10-Q · Aug 12
Up next
Next earnings call
Nov 11, 2026
Est · unconfirmed
· in 6 wks
filed Aug 12, 2026
call held Aug 12, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$26.43M
Trailing 12 months
Net income (TTM)
−$20.42M
Trailing 12 months
Revenue growth YoY
+103.2%
Year over year
Operating margin
-24.8%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$473,000
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+56.9%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
1.6%
Latest settlement · 7.8 days to cover
AI Brief
Q2 FY26 earnings call · Aug 12, 2026
Q2 FY26
TL;DR. QTI more than doubled Q2 revenue to $7.4M (+103% YoY) on 15 scanner shipments, reaffirmed 2026 guidance of ~$39M, secured a $10M public offering plus a two-year extension of its term loan, and expanded its direct U.S. sales team and international regulatory footprint (Saudi Arabia, Israel).
Bullish
- + Reaffirmed full-year 2026 revenue guidance of ~$39M, more than double 2025
- + Secured regulatory authorizations in Saudi Arabia (SFDA) and Israel (AMAR), plus upcoming Israel clinical study at Rambam
Bearish
- − Q2 net loss widened to $11.1M from $4.0M, driven by $8.3M non-cash debt extinguishment loss
- − Operating expenses rose to $4.9M from $2.9M, expanding the operating loss
- − Term loan interest rate increased from 10% to 12% as part of the maturity extension
- − Geopolitical developments have impacted commercial activity in parts of the Gulf region
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−45%
below
Price vs 50-day avg
−3%
below
RSI (14)
50
neutral
MACD trend
Positive
52-week position
1%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−3%
trailing
6-month return
−61%
trailing
YTD return
−56%
this year
Relative strength
−73%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $5 — 200d above 50d
Institutional flow
Accumulating
+36% holders QoQ · +10 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.60% of float · ▼ -12.6% MoM · 7.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
30 holders — near 3-yr high, broad support
Squeeze score
47
elevated · 0–100
Fundamentals
EPS growth
+6%
Y/Y
Free cash flow
$-9.1M
Balance sheet
$303.0K
net cash
Quant / Vol
risk profile
Volatility
104%
annualized · 1-yr
Max drawdown
−93%
past year
ATR
9.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Aug 12, 2026
Revenue
· for the year
$39M
prior FY $18.93M
midpoint +106.1% Y/Y
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−45%
Bearish
Price vs 50-day avg
−3%
Neutral
RSI (14)
50
Neutral
MACD trend
Positive
Bullish
52-week position
1%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $3 › 200d $5 — 200d above 50d
Institutional flow
Accumulating
+36% holders QoQ · +10 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.60% of float · ▼ -12.6% MoM · 7.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
30 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $2
Now $3 · 1%
Range high $36
vs 200-day avg -45%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | -$3.12M | Six Months Ended June 30, 2026 | — |
| Breast Acoustic CT scanners shipped | 28 | first six months of the year | — |
| EBITDA non-GAAP | -$12.76M | Six Months Ended June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
QTI
this stock
Qt Imaging Holdings, Inc.
|
$35.86M | -56.2% | +287.9% | — | 1.6% |
|
ABT
Abbott Laboratories
|
$174.90B | -22.2% | +5.7% | 28.1 | 1.1% |
|
MDT
Medtronic plc
|
$113.38B | -10.1% | +8.4% | 21.8 | 1.3% |
|
SYK
Stryker Corp
|
$104.47B | -21.6% | +11.2% | 28.2 | 2.0% |
|
BSX
Boston Scientific Corp
|
$63.59B | -55.3% | +12.5% | 17.8 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| QTI | +9.0% | -2.9% | -61.0% | +4.9% | -56.2% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | +9.2% | -2.5% | -73.2% | +4.0% | -69.1% |